Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immunological Tests Detects Schistosomiasis in Low-Endemicity Area

By LabMedica International staff writers
Posted on 02 Apr 2014
The prevalence of Schistosoma mansoni infection has been systematically determined using the indirect immunofluorescence assay-immunoglobulin M (IFA-IgM) and circumoval precipitin test (COPT) techniques with serum samples.

Schistosomiasis is a major public health problem, with an estimated 200 million people infected worldwide and as a consequence of effective schistosomiasis control programs based on mass or selective chemotherapy, basic sanitation measures, and use of molluscicides, the prevalence of human schistosomiasis has decreased considerably.

Parasitologists from the University of São Paulo (Brazil) conducted a cross-sectional study was from April to December 2011 in several districts on the outskirts of Barra Mansa, Rio de Janeiro, Brazil and collected 572 randomized feces and serum samples. More...
The majority of subjects in the study population were females. The average age of the population was 40 to 41 years old.

Fecal samples were processed and evaluated using the qualitative-quantitative Helm Test Kit (KK-HH, Biomanguinhos Fiocruz; Rio de Janeiro, Brazil). The COPT was used to detect antibody reactions against excretion and secretion products of S. mansoni eggs using previously described techniques. The IFA-IgM reading was performed using an Olympus BX-FLA fluorescence microscope (Olympus Corporation, Tokyo, Japan) equipped with an epi-illumination system.

The IFA-IgM identified the greatest number of S. mansoni infections (91/572, 15.9%), followed by COPT (29/572, 5.1%). The Helm test kit parasitological techniques identified the fewest infections (5/572, 0.9%). The COPT positivity showed a statistically significant difference compared with parasitological techniques. The level of agreement between COPT and parasitological techniques was higher than that with IFA-IgM. The higher COPT positivity compared with parasitological techniques may be caused by oviposition occurrence, where eggs deposited in the deepest layers of the intestine can be detected even in the absence of eggs in feces, especially in chronic infections in patients over 40 years of age and with low parasite load.

The authors concluded that positivity rates were highest using IFA-IgM compared with parasitological techniques and COPT. Therefore, it could be used as a primary approach to screen a large number of suspected cases of schistosomal infection in epidemiological studies, in combination with the KK-HH techniques and confirmation of IFA-IgM-positive cases with COPT techniques would be beneficial in low-endemicity areas. The study was published on March 17, 2014, in the American Journal of Tropical Medicine and Hygiene.

Related Links:
University of São Paulo
Biomanguinhos
Olympus Corporation



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.